A detailed history of Bell Investment Advisors, Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 107 shares of IOVA stock, worth $801. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107
Previous 43 148.84%
Holding current value
$801
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.28 - $11.9 $465 - $761
64 Added 148.84%
107 $1,000
Q2 2024

Aug 07, 2024

BUY
$7.78 - $14.19 $334 - $610
43 New
43 $0
Q2 2023

Aug 09, 2023

BUY
$5.36 - $9.06 $337 - $570
63 New
63 $0
Q2 2022

Aug 12, 2022

SELL
$6.38 - $18.33 $446 - $1,283
-70 Reduced 57.85%
51 $1,000
Q4 2021

Feb 14, 2022

BUY
$16.55 - $27.63 $1,357 - $2,265
82 Added 210.26%
121 $2,000
Q3 2021

Nov 12, 2021

BUY
$20.35 - $26.63 $793 - $1,038
39 New
39 $1,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.18B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.